+ All Categories
Home > Documents > Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight®...

Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight®...

Date post: 13-Apr-2020
Category:
Upload: others
View: 1 times
Download: 0 times
Share this document with a friend
13
6/24/2013 1 Refractive and Refractive Cataract Surgery: What can we treat and who don’t we want to treat Karl Stonecipher, MD Clinical Assistant Professor of Ophthalmology, UNC Medical Director, TLCGreensboro Financial Interest Disclosure Alcon – consultant/grants/research/speaker/travel Allergan – consultant/grants/research/speaker/travel B &L consultant/travel/speaker LaserACE – consultant/MAB LenSx – consultant/research/MAB Nexus – consultant/research/MAB Nidek – consultant/grants/research Refocus – consultant/grants/research/speaker/travel TLCmedical director 1800 DoctorsMAB 2 Refractive Surgery Who are our patients? Where are we with Laser Vision Correction Today? Life lessons from Dr. Karl….. LVC Procedures by Quarter 182,650 153,351 137,322 149,375 186,470 156,877 134,835 145,532 192,740 50 000 100,000 150,000 200,000 250,000 VC Procedures (000) LASIK 0 50,000 L V *Estimated Copyright 2013, Market Scope, LLC Femtosecond Laser Flaps vs. Mechanical Laser Flaps Preference 30% 40% 50% 60% 70% 80% 90% 100% Copyright 2013, Market Scope, LLC 0% 10% 20% 30% Q12007 Q22007 Q32007 Q42007 Q12008 Q22008 Q32008 Q42008 Q12009 Q22009 Q32009 Q42009 Q12010 Q22010 Q32010 Q42010 Q12011 Q22011 Q32011 Q42011 Q12012 Q22012 Q32013 Q42014 Femtosecond Flaps Mechanical Flaps
Transcript
Page 1: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

1

Refractive and Refractive Cataract Surgery:  

What can we treat and who don’t we want to treat

Karl Stonecipher, MD

Clinical Assistant Professor of Ophthalmology, UNC

Medical Director, TLC‐Greensboro

Financial Interest Disclosure

• Alcon – consultant/grants/research/speaker/travel

• Allergan – consultant/grants/research/speaker/travel

• B &L – consultant/travel/speaker

• LaserACE – consultant/MAB

• LenSx – consultant/research/MAB

• Nexus – consultant/research/MAB

• Nidek – consultant/grants/research

• Refocus – consultant/grants/research/speaker/travel

• TLC‐medical director

• 1800 Doctors‐MAB

2

Refractive Surgery

Who are our patients?

Where are we with Laser Vision Correction 

Today?

Life lessons from Dr. Karl…..

LVC Procedures by Quarter

182,650

153,351137,322

149,375

186,470

156,877134,835145,532

192,740

50 000

100,000

150,000

200,000

250,000

VC Proce

dures (000

) LASIK

0

50,000LV

*Estimated

Copyright 2013, Market Scope, LLC 

Femtosecond Laser Flaps vs. Mechanical Laser Flaps  Preference 

30%

40%

50%

60%

70%

80%

90%

100%

Copyright 2013, Market Scope, LLC 

0%

10%

20%

30%

Q1‐2007

Q2‐2007

Q3‐2007

Q4‐2007

Q1‐2008

Q2‐2008

Q3‐2008

Q4‐2008

Q1‐2009

Q2‐2009

Q3‐2009

Q4‐2009

Q1‐2010

Q2‐2010

Q3‐2010

Q4‐2010

Q1‐2011

Q2‐2011

Q3‐2011

Q4‐2011

Q1‐2012

Q2‐2012

Q3‐2013

Q4‐2014

Femtosecond Flaps Mechanical Flaps

Page 2: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

2

Where are the Patients Coming From?

Copyright 2013, Market Scope, LLC 

Key Take Aways from Current Data

• LVC procedures are on the rise again.

• Femtosecond flaps for LVC surgery are now the most common flaps in the US.  

• Satisfied patients are the best source of new patients.

External Factor Affecting LVC• Demographic shift

– Baby Boomers

– Millennials

• Gen X profile

• Gen Y profile• Gen Y profile

Only generation besides the Boomers to have ≥ 4 million births per year

Source:  CRST MM ACOS 2012 Dear Valley Meeting

Cost and the outcome are considered the most important factors in the decision to have 

LVC

Men Women

ance

Cost Outcome Fear Convenience Recovery

Impo

rta

• For women, the outcome was the top factor, followed closely by cost• For men, however, cost was the top factor by a fairly large margin

Source: Consumer Barrier Research N=73,  Data on File 

Consumer Challenges to Consider

C ?

Outcomes?

F ?

Consumer

Cost? Fear?

What are Refractive Patients Looking for?

Quality of Life

–Education on their options–Improvement in their vision

–Spectacle Freedom–A surgeon’s recommendation

Page 3: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

3

What about the ocular surface?

Lid pattern staining Diffuse staining Meibomian glanddiseaseAqueous tear deficiency

Regimen V. NO REGIMEN AND THE EFFECT ON Postoperative day 1 UCVA

• Topical Corticosteroid– 4x/day for the days prior to surgery

• Topical Fluroquinolone– 4x/day for the days prior to surgery

• If you work in a medical environment,

• I add Polytrim or Gentamicin

• (Trust Study)

Stonecipher, K, McMackin, K:  Postoperative day 1 visions: Is it the laser or the regimen, how do we improve outcomes, ESCRS,Sept 2009

The Reasons

• Improved Lid Margin Hygiene

• Improved Lids promote an improved Tear Film

• Improved Tear Film allows for better diagnostics on the day of surgery

• What goes in the computer is what comes out

• Better numbers equals Better Vision and outcomes as soon as day one

• Better outcomes means Less Enhancements

Final Comparison Myopia

Final Comparison‐Hyperopia Conclusions

• There was an improvement in UCVA at the POD 1 level related to the switch from the microkeratome to the femtosecond laser.

• The major improvement in POD 1 UCVA was related to the preoperative regimen of a corticosteroid 4x/day and a fluroquinolone4x/day for 3 days preoperatively.

Page 4: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

4

Therapeutics

COULD IT BE WE NEED TO 

WORK ON THE OCULAR SURFACE?

Image from: Dry Eye and Ocular Surface Disorders, 2004

Dry Eye Following LASIK• Reported incidence of over 50%, but reports vary widely– 21% of LASIK patients seeking consultation for complications complained of dry eye

• Most common within 6 months• Most common within 6 months postsurgery, but may last a year or more

• Reduced incidence with FS laser flaps

Solomon et al. J Cataract Refract Surg. 2002; Albietz et al. Adv Exp Med Biol. 2002; Jabburet al. J Cataract Refract Surg. 2004; Tanaka et al. J Cataract Refract Surg. 2004; Toda et al. 

Am J Ophthalmol. 2001. Albietz et al. J Refract Surg. 2002.

80%

100%92%

100%

79.7%

93.2%94.3%

Cyclosporine Study

0%

20%

40%

60%

20/10 20/12.5 20/16 20/20 20/25

37%

2.2%

21.3%

POD 1

3 months

PROFILE

COULD IT BE WE NEED TO 

WORK ON THE LASER ABLATION PROFILE?

Slide courtesy of PD Dr. Michael Mrochen / IROC ‐ Zurich, Switzerland 

WFO WFG

Ray T i

WFO WFG

Ray Tracing

Custom-Q Topography-Guided

Tracing

Custom‐Q Topography‐Guided

Ray Tracing 0 30.40.50.60.70.80.91

58%

98%

69%

84%92% 95%

POD 1

3 months

TCAT

00.10.20.3

20/10 20/12.5 20/16 20/20 20/25

2%

28%

3%

Page 5: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

5

REFRACTIONCOULD IT BE WE NEED 

To WORK ON THE DATA

INPUT AND OUTPUT?

20%

40%

60%

80%

100%

50%

94%100%

19% 19%

56%

94%100%

POD 1

3 months

0%

20%

20/10 20/12.5 20/16 20/20 20/25

6%

Wavefront optimized

WFO=Pure Refractive treatment with reduced induction of HOA’s

How do you measure success?

EnhancementsOutcomes

BCVA=UCVAPatient Satisfaction

94%96%

97%

94% 94%94%96%

91%

81%80%

90%

100%

WFG‐LASIK (n=14,277)

Conv‐LASIK (n=1,085)

Insufficient data

Patient SatisfactionWFG vs Conventional LASIK (all fs flaps)

70%High Myopia Mod myopia Low Myopia Low Hyper High Hyper

Preoperative Sphere

Wavefront Outcomes of Custom LASIK, PRK, and IntraLASIK, Shallhorn, s, et all, WFC, Vancouver, BC

POD 1 UCVA

0.8

1

1.2

1.4

1.6

1.8

2

1.13 1.12 1.111.1 1.11 1.11

Preop BCVAPostop UCVA

20/20=1.0

0

0.2

0.4

0.6

TCAT Restasis WFO

Page 6: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

6

Femtosecond and Femtosecond and ExcimerExcimer LasersLasers

• Combination of femtosecond flap with excimer laser ablation for 100% of primary LASIK procedures.

• Good technologies available by several manufacturers

VISXStar S4*/IR

WaveLight® Allegretto Wave® Eye-Q

Tracker Speed 60Hz 400Hz

US Rx DFU Myopia, Hyperopia, Mixed, PTK

Myopia, Hyperopia, Mixed

Wavefront Optimized®

AblationNo Yes

Wavefront Guided Ablation Yes Yes

Excimer Laser

Technical Technical DetailsDetails

Wavefront Guided Ablation Yes Yes

Iris Registration Yes No

Spot Size Variable 0.65 -5.0mm 0.95mm

Beam Profile Flat Top Gaussian

Laser Speed Variable 6-20 Hz 400 Hz

*Trademarks are property of their respective owners **Data on File

Refractive Refractive Surgery Surgery CConsultantonsultant‐‐200 200 HzHz

*Personal Data on File: Courtesy of Karl Stonecipher, MD

Internet based refractive analysisInternet based refractive analysis‐‐400 400 HzHz

289 of 312

*Personal Data on File: Courtesy of Karl Stonecipher, MD

•Controlling the peripheral ablation profile allows for:– Large, true optical zones 

– Minimized and smooth transition zones

– And with up to 9‐mm treatment diameter, minimal induction of nighttime glare1

Wavefront Optimized® optical zone

Optimizing the Optical Zone

Wavefront Optimized® treatments result in a large true aspheric zone and a minimized transition zone

1. FDA Clinical Study Supplement 4PO20050/S4

What About the Laser Technology

Femtosecond Laser Excimer Laser

Page 7: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

7

What about the Data Input

1. Refraction

2. Refraction

3. Refraction

4 Ocular Surface4. Ocular Surface

5. Nomogram

Acuity of Pilots (N=140) &Clinic Patients (N=288)

40%

60%

Acuity 5% LCAMesopic 25% 100%

Pilot:Patient:

0%

20%

20/8 20/10 20/12.5 20/16 20/20 20/25 20/32.5 20/40 20/50 20/62.5 20/80

Visual AcuityData Courtesy of Steve Schalhorn, 

It depends where you start…..

Nomograms Have Multiple Influences

Speed of the SurgeonTechnique of the Surgeon Laser PlatformTemperature 

Manifest RefractionAgeMyopia Hyperopia

HumidityOcular Surface DiseaseTracking

Astigmatism Speed of the laserRegistration

WavefrontWavefront OptimizedOptimized® ® AblationAblation ‐‐400 Hz*400 Hz*

40%

50%

60%

70%

80%

90%

100%

39%

83%

96%

78%

96%99%

POD 1

3 month

0%

10%

20%

30%

20/12 20/16 20/20 20/25

3%

15%

• Wavefront Optimized® Treatment=Pure Refractive treatment with reduced induction of HOA’s

• Stonecipher finding support FDA Clinical Data

N=313

*Personal Data on File: Courtesy of Karl Stonecipher, MD

Enhancements Cost More than Money

1. Patients think of an enhancement as failure of the procedure 

2. Enhancements cost us around $500.00/case

3. Lost surgery slot and consultation slot

4. Loss of patient referrals because it didn’t workp

5. Decreased doctor referrals because you had to do it twice

6. Lost play time because your wasting your time doing enhancements.

Enhancement Rates

4.17%

%

3.00%

4.00%

5.00%

1.14% 0.88% 0.70%

0.00%

1.00%

2.00%

Mechanical+200Hz Excimer

IL 10Hz +200Hz Excimer 2002‐2005

IL 150Hz +400Hz Excimer 2006‐2010

WL Refractive Workstation 2011‐2012

Enhacements Through the Years

Personal Data on File: Courtesy of Karl Stonecipher, MD

Page 8: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

8

Patient SatisfactionPatient Satisfaction

• In our practice patients say:– “It went by quickly”– “No big deal”– “I only remember one laser”– “Your staff is awesome”– “Your staff treated me like 

f h f l ”I was part of the family”

• Minimal wait time 

• Procedure flow

• Outcomes

COMPARISON OF POSTOPERATIVE DAY 1 AND MONTH 1 VISUAL OUTCOMES BETWEEN LASER VISION CORRECTION AND FEMTOSECOND CATARACT SURGERY

IS THE FEMTOSECOND 

LASER REALLY 

WORTH 

IT?

METHODS

• 2 GROUPS (N‐103)– LENSX– CE IOL

• OUR CENTER HAS DONE OVER 1300 CASES  (3 SURGEONS)• THIS SERIES CONSECUTIVE PATIENTS FROM ONE SURGEON 

(KGS)(KGS)• PATIENTS TARGETED FOR PLANO• 2.7 MM INCISION LENGTH• PREMIUM  IOL CHANNEL PATIENTS• NO RETINAL OR SYSTEMIC PATHOLOGY• NO COMPLICATIONS INTROPERATIVELY OR 

POSTOPERATIVELY

AXIAL LENGTH

• LENSX– AVERAGE 24.2+/‐1.3 MM

– RANGE 20.97 TO 28.46

• CE IOL– AVERAGE 23.3+/‐.5 MM

– RANGE 21.25 TO 27.67

100.0

150.0

64.5

133.8

LENSX

CE IOL

A 64% REDUCION IN US TIME

ULTRASOUND TIMES

0.0

50.0

Seconds

"Compared to control porcine eyes, femtosecond laser phacofragmentation resulted in a 43% reduction in phacoemulsification power and a 51% decrease in phacoemulsification time."Nagy Z, Takacs A, Filkorn T, Sarayba M. Initial clinical evaluation of an intraocular femtosecond laser in cataract surgery. J Refract Surg. 2009 Dec;25(12):1053‐60.

POD 1 AVERAGE UCVA

LENSX• Day 1 Average• 0.74+/‐.21

CE IOL• Day 1 Average• 0.69+/‐.1

Page 9: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

9

POD 1 UCVA

60%

70%

80%

90%

100%

67%

98%

50%

59%

77%

0%

10%

20%

30%

40%

50%

60%

20/15 20/20 20/25 20/30 20/40

4%

27%

42%

0%

35%LenSx

CE IOL

MONTH 1 AVERAGE UCVALENSX• Month 1 Average

• 0.9+/‐0.19

• SE ‐0.23+/‐0.47 D

CE IOL • Month 1 Average

• 0.82+/‐.29

• SE ‐0.44+/‐0.41 D

MONTH 1 UCVA

60 0%

70.0%

80.0%

90.0%

100.0%

55 0%

81.0%

94.0%100.0%

52 0%

65.0% 68.0%

87.0%

0.0%

10.0%

20.0%

30.0%

40.0%

50.0%

60.0%

20/15 20/20 20/25 20/30 20/40

10.0%

55.0%

10.0%

52.0%LENSX 

CE IOL

WHAT ABOUT LASIK VS FS VS MANUAL?

• Overall 81% of the FS laser group saw 20/30 or better at 1 month compared to 65% of the manual group. 

• In a comparative set of LASIK patients overall• In a comparative set of LASIK patients, overall 98% of the LASIK group saw 20/20 or better at 1 month and 89% of the group saw 20/20 at POD 1. 

SUMMARY

• 64% REDUCTION IN ULTRASOUND TIME

• POD 1 100% <20/40 LENSX v 77 % CE IOL

• POD 1 67% <20/30 v 59% CE IOL

MONTH 1 100% <20/40 LENSX 87% CE IOL• MONTH 1 100% <20/40 LENSX v 87% CE IOL

• MONTH 1 94% <20/30 LENSX v 68% CE IOL

Enhancements

Is this a dirty word?

Page 10: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

10

LIFETIME COMMITTMENT OTHER OPTIONS

These are what we do…

REASONS‐LASIK

Poor refractions Head alignmentPoor wavefronts Regression

Dry Eye Disease 

REASONS‐CATARACT

Poor biometry Wrong lens Dry eye disease  Wrong patient

Residual Refractive Error     Poor lens alignment

PEARLS TO LIVE BYNo man left behind...

Doug Katsev

Remember you always get injured on your last run…………

When to Enhance

– Unhappy with current vision– No anatomical issues to enhance– Understands the risks of having a new procedure

– Has the appropriate expectations this is– Has the appropriate expectations… this is even more important to understand than for the primary procedure.

– UCVA justifies an enhancement – RX justifies an enhancement

• Aggressive preoperative management of ocular surface disease

• Diagnostics, diagnostics, diagnostics (Know what  you have before you start)

How to prevent enhancements

• Measure twice cut once

• Monitor you outcomes to help get better results

• Establish patient expectations 

Page 11: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

11

Incidence of Concomitant Cataract & Dry Eye: A Prospective Health Assessment of 

Cataract Patients’ Ocular surface

William Trattler MDWilliam Trattler, MD

Damien Goldberg, MD, Charles Reilly, MD, Mark Packer, MD, Parag Majmudar, MD, Eric Donnenfeld, MD, Marguerite 

McDonald, MD, Jon Vukich, MD, Gregg Berdy, MD, Ranjan Malahotra, MD, and Karl Stonecipher,MD

71ePoster Trattler, et al, ASCRS, 2011

Results:  Tear Break up Time

• Average TBUT:  4.93 seconds – # of eyes with TBUT ≤ 5 seconds: 126 eyes (61.7%)

– # of eyes with TBUT ≤ 7 seconds: 169 eyes (82.8%)

Tear Break up

SLIDE COURTESY OF BILL TRATTLER, MD

Corneal Staining

• Positive Corneal Staining:  154 eyes  (75.5%)

• Central Corneal Staining:   92 eyes (45.1%)

Central Corneal Staining

SLIDE COURTESY OF BILL TRATTLER, MD

Summary of PHACO Study• Dry eye signs are very common in patients scheduled for cataract surgery– TBUT:  

• More than 60% with very abnormal TBUT (≤ 5 seconds))

– 83% with TBUT TBUT ≤ 7 seconds

– Corneal Staining• 45% with Central staining

– Schirmer’s score• 18.6% with very low Schirmer’s (≤5mm)

SLIDE COURTESY OF BILL TRATTLER, MD

A New Approach: 

WaveTec Vision’s

Intraoperative Wavefront Technology

Standard Toric Cases Cylinder Reduction

Pre-op Keratometric AstigmatismN= 86, Mean Cyl 1.91 ± 0.90

Post-op Refractive CylinderN= 86, Mean Cyl 0.50 ± 0.40

*Dr Stonecipher & Dr Woodcock Toric Data

Page 12: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

12

Standard Toric CasesPost Op Cylinder Distribution

69%

81%92%

60%

80%

100%

37%

0%

20%

40%

≤0.25 ≤0.5 ≤0.75 ≤1

N=86*Dr Stonecipher & Dr Woodcock Toric Data

POD 1 UCVA

40%

50%

60%

70%

80%

90%

100%

33%

72%

100%

35%

53%

71%

LenSx

CE IOL

UCVAPOD 1 VS MONTH 1FSLC VS CE IOL

0%

10%

20%

30%

20/15 20/20 20/25 20/30 20/40

0%

22%

0%

18%IOL

WHAT WE HAVE DONE…..

• SLIT LAMP LIMBAL RELAXING INCISIONS

• OPERATING ROOM LIMBAL RELAXING INCISIONS

VIDEO COURTESY ERIC DONNENFELD,MD

The Enhancement• Primary Procedure was PRK or LASIK:

– Choices for enhancement are PRK, LASIK, Custom (LASIK or PRK), Laser Astigmatic Incisions, AK.

– +/‐MMC• Primary Procedure was RK:

– May consider RLE or CE IOL depending on age– Enhancement procedure can be LASIK  or PRK (with MMC) – IntraLase is not an option, as the gas can escape through 

the RK incisions. • Primary Procdedure was Cataract Surgery

– IOL Exchange or Piggyback IOL– Choices for enhancement are PRK, LASIK, Custom (LASIK 

or PRK), Laser Astigmatic Incisions, AK.– +/‐MMC

Arcuate Astigmatic IncisionsExcellent precision, depth, length, axis

3 hours post-op lri laser incision

PHOTOS  COURTESY OF ROBERT CIONNI, MD

PRK Enhancements

Transepithelial Alcohol Removal

MYOPIC AND MYOPIC ASTIGMATIC ENHANCEMENTS

CUSTOM, MIXED ASTIGMATISM, HYPEROPIC AND HYPEROIC ASTIGMATIC ENHANCEMENTS

Page 13: Refractive Where are we with Laser Vision Correction Today? · 2014-04-07 · WaveLight® Allegretto Wave® Eye-Q Tracker Speed 60Hz 400Hz US Rx DFU Myopia, Hyperopia, Mixed, PTK

6/24/2013

13

Transepithelial PRK• 50‐58 micro PTK

– 54 micron PTK• No previous surgery 

– 58 micron PTK• Previous surgery

• PTK diameter 6.5 mm

• Spherical Adjustment– 0.66 D

• Standard PRK 6.0 mm

• 12S MMC if indicated– Apply in all Enhancements

• Frozen BSS Irrigation

• Medications + BCL

0 4

‐0.2

0Sph Eq Cylinder

‐0.2‐0.08

Myopia PreEnh v PostEnh‐1.2

‐1

‐0.8

‐0.6

‐0.4

‐1.07

‐0.44PreEnh

PostEnh

Preop BCVA v. UCVA Post‐Enh v Postop BCVA

0.70.80.91

0.93 0.941.04

Visual Acuity20/20 20/2020/20

00.10.20.30.40.50.6

Preop BCVA Postop UCVA Postop BCVA

Visual Acuity


Recommended